Last reviewed · How we verify
NCT06158035
ED90 of Norepinephrine and Phenylephrine Boluses Under Intensive Treatment in Preeclamptic Patients
NA trial testing Norepinephrine in Adverse Effect in 80 participants. Status unknown.
30 December 2025
Quick facts
| Lead sponsor | General Hospital of Ningxia Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 July 2025 |
| Primary completion | 30 December 2025 |
| Estimated completion | 30 December 2025 |
Drugs / interventions tested
- Norepinephrine (NOREPINEPHRINE) — full drug profile →
- Phenylephrine (phenylephrine) — full drug profile →
Conditions studied
- Adverse Effect — all drugs for Adverse Effect →
Sponsor
General Hospital of Ningxia Medical University
Who can join
Adults 18 to 45, female only, with Adverse Effect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to investigate the ED90 of norepinephrine and phenylephrine boluses for treating postspinal anesthesia hypotension under intensive treatment in preeclamptic patients during cesarean section
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06158035
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Norepinephrine
Trials testing the same drug.
- NCT07322133 — Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE) · Phase 4 · recruiting
- NCT06921473 — Effect of Ephedrine vs. Norepinephrine on Prevention of Fetal Acidosis During Cesarean Section Under Spinal Anesthesia · Phase 4 · completed
- NCT06977659 — Early Norepinephrine in Trauma Patients With Hemorrhagic Shock · Phase 1, PHASE2 · enrolling by invitation
- NCT06344442 — Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR · Phase 3 · recruiting
- NCT06574555 — Norepinephrine ED90 Bolus After Spinal Anesthesia in Cesarean Section · Phase 4 · completed
Other recruiting trials for Adverse Effect
Currently open trials in the same condition.
- NCT06570629 — Addressing Unintentional Leakage When Using Nasal CPAP - Study B · NA · recruiting
- NCT06570616 — Addressing Unintentional Leakage When Using Nasal CPAP - Study A · NA · recruiting
- NCT06467045 — Frequency of Adverse Events in Pediatric Patients Receiving Sedation for Magnetic Resonance Imaging · recruiting
Other General Hospital of Ningxia Medical University trials
Trials by the same sponsor.
- NCT07496086 — External Oblique Intercostal Block Versus Transversus Abdominis Plane Combined With Rectus Sheath Block on Postoperative · NA · recruiting
- NCT07396545 — External Oblique Intercostal Block Versus Erector Spinae Plane Block on Postoperative Pain in Laparoscopic Radical Gastr · NA · recruiting
- NCT07366853 — Feasibility and Safety of Sciatic Nerve Paraneural Sheath Block Using a Mid-Femoral Lateral Approach · NA · not yet recruiting
- NCT07239531 — The Application of Intermittent Training in Clinical Skills Simulation Training · NA · not yet recruiting
- NCT07248683 — Application of Intermittent Training in Radial Artery Puncture and Catheterization Skills Under Ultrasound-Guided Line G · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06158035 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by General Hospital of Ningxia Medical University
- Last refreshed: 6 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06158035.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing